322 related articles for article (PubMed ID: 28036030)
21. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
Kim do Y; Park EY; Chang E; Kang HG; Koo Y; Lee EJ; Ko JY; Kong HK; Chun KH; Park JH
Oncotarget; 2016 Mar; 7(12):14791-802. PubMed ID: 26895471
[TBL] [Abstract][Full Text] [Related]
22. Doxorubicin and α-Mangostin oppositely affect luminal breast cancer cell stemness evaluated by a new retinaldehyde-dependent ALDH assay in MCF-7 tumor spheroids.
Bissoli I; Muscari C
Biomed Pharmacother; 2020 Apr; 124():109927. PubMed ID: 31982725
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.
Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
Exp Cell Res; 2013 Dec; 319(20):3140-9. PubMed ID: 24012960
[TBL] [Abstract][Full Text] [Related]
24. Effect of pyruvate kinase M2-regulating aerobic glycolysis on chemotherapy resistance of estrogen receptor-positive breast cancer.
Qian Y; Bi L; Yang Y; Wang D
Anticancer Drugs; 2018 Aug; 29(7):616-627. PubMed ID: 29782350
[TBL] [Abstract][Full Text] [Related]
25. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
26. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Prostate Cancer Cells after Treatment with Xanthohumol-A Natural Compound Present in Humulus lupulus L.
Kłósek M; Mertas A; Król W; Jaworska D; Szymszal J; Szliszka E
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338375
[TBL] [Abstract][Full Text] [Related]
27. Preliminary study of the effects of β-elemene on MCF-7/ADM breast cancer stem cells.
Dong Y; Li L; Wang L; Zhou T; Liu JW; Gao YJ
Genet Mol Res; 2015 Mar; 14(1):2347-55. PubMed ID: 25867381
[TBL] [Abstract][Full Text] [Related]
28. Cytoprotective effects of xanthohumol against methylglyoxal-induced cytotoxicity in MC3T3-E1 osteoblastic cells.
Suh KS; Chon S; Choi EM
J Appl Toxicol; 2018 Feb; 38(2):180-192. PubMed ID: 28940469
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
Wang ZX; Lu BB; Wang H; Cheng ZX; Yin YM
Arch Med Res; 2011 May; 42(4):281-90. PubMed ID: 21820606
[TBL] [Abstract][Full Text] [Related]
30. Xanthohumol induces generation of reactive oxygen species and triggers apoptosis through inhibition of mitochondrial electron transfer chain complex I.
Zhang B; Chu W; Wei P; Liu Y; Wei T
Free Radic Biol Med; 2015 Dec; 89():486-97. PubMed ID: 26453927
[TBL] [Abstract][Full Text] [Related]
31. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of xanthohumol from hops (Humulus lupulus L.) on human hepatocellular carcinoma cell lines.
Ho YC; Liu CH; Chen CN; Duan KJ; Lin MT
Phytother Res; 2008 Nov; 22(11):1465-8. PubMed ID: 18814205
[TBL] [Abstract][Full Text] [Related]
33. Salubrinal-Mediated Upregulation of eIF2α Phosphorylation Increases Doxorubicin Sensitivity in MCF-7/ADR Cells.
Jeon YJ; Kim JH; Shin JI; Jeong M; Cho J; Lee K
Mol Cells; 2016 Feb; 39(2):129-35. PubMed ID: 26743901
[TBL] [Abstract][Full Text] [Related]
34. Binding of the hop (Humulus lupulus L.) chalcone xanthohumol to cytosolic proteins in Caco-2 intestinal epithelial cells.
Pang Y; Nikolic D; Zhu D; Chadwick LR; Pauli GF; Farnsworth NR; van Breemen RB
Mol Nutr Food Res; 2007 Jul; 51(7):872-9. PubMed ID: 17579893
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effects of xanthohumol, a prenylated flavonoid from hops (Humulus lupulus), in ischemic stroke of rats.
Yen TL; Hsu CK; Lu WJ; Hsieh CY; Hsiao G; Chou DS; Wu GJ; Sheu JR
J Agric Food Chem; 2012 Feb; 60(8):1937-44. PubMed ID: 22300539
[TBL] [Abstract][Full Text] [Related]
36. Xanthohumol: An underestimated, while potent and promising chemotherapeutic agent in cancer treatment.
Vesaghhamedani S; Ebrahimzadeh F; Najafi E; Shabgah OG; Askari E; Shabgah AG; Mohammadi H; Jadidi-Niaragh F; Navashenaq JG
Prog Biophys Mol Biol; 2022 Aug; 172():3-14. PubMed ID: 35405185
[TBL] [Abstract][Full Text] [Related]
37. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
Park SJ; Wu CH; Safa AR
Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
[TBL] [Abstract][Full Text] [Related]
38. Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway.
Huang Q; Wu YY; Xing SJ; Yu ZW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5285-5292. PubMed ID: 31298380
[TBL] [Abstract][Full Text] [Related]
39. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
Zhang ZL; Jiang QC; Wang SR
Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
[TBL] [Abstract][Full Text] [Related]
40. USP37 downregulation elevates the Chemical Sensitivity of Human Breast Cancer Cells to Adriamycin.
Qin T; Cui XY; Xiu H; Huang C; Sun ZN; Xu XM; Li LH; Yue L
Int J Med Sci; 2021; 18(2):325-334. PubMed ID: 33390801
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
